Thu, December 16, 2021

Carter Gould Maintained (TVTX) at Buy with Increased Target to $40 on, Dec 16th, 2021

Carter Gould of Barclays, Maintained "Travere Therapeutics, Inc." (TVTX) at Buy with Increased Target from $36 to $40 on, Dec 16th, 2021.

Carter, nor any peers, have made any analyst calls on TVTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30